Clinigen Group PLC

Clinigen Group says acquisitions fueling expected profit growth in its trading update

Clinigen Group PLC (LON:CLIN) Head of Investor Relations Matthew Parrish tells Proactive Investors the company's recent trading update indicates that profits at the pharma services company are expected to have soared by more than a third when it reports its full-year results in September.

Gross profits were up 30%, while revenues increased by 19%, and Parrish says this significant growth was driven by M&A with the firm having closed two of its largest ever acquisitions last year.

Quick facts: Clinigen Group PLC

Price: £8.76

Market: AIM
Market Cap: £1.16 billion


Clinigen makes strong start to second-half

Clinigen PLC (LON:CLIN) is predicting another half of “good progress” as it said adjusted earnings and cash flow grew strongly in the six months to the end of December. CEO Shaun Chilton tells Proactive London how the change was achieved since he took the helm of Clinigen three years ago. The...

on 28/2/19

2 min read